Apply Now

News » Archives » June 2016

Michael Hildreth is the Next Associate Dean for Research and Graduate Studies

Author: Tammi Freehling

Mike Hildreth, Associate Dean

Michael Hildreth is appointed the next Associate Dean for Research and Graduate Studies effective July 1, 2016. He replaces Brian Baker, who steps down as associate dean after three years of leadership. Says Hildreth of his new role, “I’m excited and humbled by this opportunity to increase the breadth and depth of research at the College. I hope to help our faculty engage with the many new opportunities for collaboration and innovation that are presented by the rapid progress of all aspects of science. It should be fun.” Read More

Understanding the Molecular Structure of Compounds in order to Advance Discovery of New Medicines and More

Author: Brandi Klingerman

Allen Oliver

At the University of Notre Dame, the Molecular Structure Facility (MSF) analyzes organic or inorganic substances at an atomic level, which allows researchers to learn about the three-dimensional structure and connectivity of the compound they have created. Knowing the molecular make-up of substances oftentimes provides faculty, postdoctoral fellows, and graduate students information about whether or not their substance is actually what was intended or even to see if their research is heading in the right direction. Read More

Engineering the immune system to kill cancer cells

Author: Tammi Freehling

Cancer research lab

In late 2015, former President Jimmy Carter announced that he was free of the metastatic melanoma that had spread to his liver and brain. In addition to surgery and radiation, Carter was treated with an immunotherapy drug, a new approach in cancer treatment that has a promising outlook. Read More

Entomologist Nicole L. Achee helps write gene drives report

Author: William G. Gilroy

Nicole Achee

University of Notre Dame medical entomologist Nicole L. Achee is a member of a committee convened to summarize the scientific discoveries related to gene drives and considerations for their responsible use. The National Institutes of Health (NIH) and the Foundation for the National Institutes of Health asked the National Academies of Sciences, Engineering and Medicine to convene the committee. Read More

Notre Dame Research to showcase Commercialization Opportunities at BIO 2016

Author: Brandi Klingerman

The University of Notre Dame will attend the 2016 BIO International Convention, which is hosted by the Biotechnology Innovation Organization (BIO) from June 6 - 9, 2016 in San Francisco. Represented Notre Dame Research groups at the event include the Harper Cancer Research Institute (HCRI), the Center for Nano Science and Technology (NDnano), as well as Technology Transfer.

Screen Shot 2016 06 06 At 8 Read More

Study reveals insights into protein linked to cancer and Alzheimer’s disease

Author: William G. Gilroy

NMR-based model for Pin1, and its interaction with its “disordered” protein targets pertinent to cancer and Alzheimer’s disease

Drugs to treat cancer and Alzheimer’s disease usually target the active sites of specific protein molecules sustaining the disease. Traditional drug design views proteins as rigid 3-D objects with active sites consisting of surface-accessible “pockets” with a specific, well-defined structure. Traditional drug design involves finding small molecules with shapes that fit specifically into this pocket. A new study from University of Notre Dame researchers suggests that there are alternative approaches to targeting these proteins, a significant finding for future clinical applications. Read More